Artelo Biosciences (ARTL) Competitors $0.87 -0.01 (-0.91%) As of 01:49 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock ARTL vs. SPRB, MTVA, HCWB, IPA, CTXR, ATHA, BMRA, NERV, ORGS, and FLGCShould you be buying Artelo Biosciences stock or one of its competitors? The main competitors of Artelo Biosciences include Spruce Biosciences (SPRB), MetaVia (MTVA), HCW Biologics (HCWB), ImmunoPrecise Antibodies (IPA), Citius Pharmaceuticals (CTXR), Athira Pharma (ATHA), Biomerica (BMRA), Minerva Neurosciences (NERV), Orgenesis (ORGS), and Flora Growth (FLGC). These companies are all part of the "pharmaceutical products" industry. Artelo Biosciences vs. Spruce Biosciences MetaVia HCW Biologics ImmunoPrecise Antibodies Citius Pharmaceuticals Athira Pharma Biomerica Minerva Neurosciences Orgenesis Flora Growth Spruce Biosciences (NASDAQ:SPRB) and Artelo Biosciences (NASDAQ:ARTL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, community ranking, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Do analysts recommend SPRB or ARTL? Spruce Biosciences presently has a consensus price target of $2.50, indicating a potential upside of 809.09%. Artelo Biosciences has a consensus price target of $5.50, indicating a potential upside of 534.37%. Given Spruce Biosciences' higher possible upside, research analysts plainly believe Spruce Biosciences is more favorable than Artelo Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spruce Biosciences 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Artelo Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Which has better valuation and earnings, SPRB or ARTL? Artelo Biosciences has lower revenue, but higher earnings than Spruce Biosciences. Spruce Biosciences is trading at a lower price-to-earnings ratio than Artelo Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpruce Biosciences$7.10M1.60-$47.92M-$0.94-0.29Artelo BiosciencesN/AN/A-$9.29M-$3.05-0.28 Is SPRB or ARTL more profitable? Artelo Biosciences has a net margin of 0.00% compared to Spruce Biosciences' net margin of -555.23%. Spruce Biosciences' return on equity of -62.10% beat Artelo Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Spruce Biosciences-555.23% -62.10% -47.49% Artelo Biosciences N/A -104.59%-94.06% Does the MarketBeat Community prefer SPRB or ARTL? Artelo Biosciences received 9 more outperform votes than Spruce Biosciences when rated by MarketBeat users. Likewise, 77.42% of users gave Artelo Biosciences an outperform vote while only 54.93% of users gave Spruce Biosciences an outperform vote. CompanyUnderperformOutperformSpruce BiosciencesOutperform Votes3954.93% Underperform Votes3245.07% Artelo BiosciencesOutperform Votes4877.42% Underperform Votes1422.58% Which has more risk & volatility, SPRB or ARTL? Spruce Biosciences has a beta of 2.34, indicating that its share price is 134% more volatile than the S&P 500. Comparatively, Artelo Biosciences has a beta of 1.06, indicating that its share price is 6% more volatile than the S&P 500. Do insiders & institutionals have more ownership in SPRB or ARTL? 91.7% of Spruce Biosciences shares are owned by institutional investors. Comparatively, 0.9% of Artelo Biosciences shares are owned by institutional investors. 9.1% of Spruce Biosciences shares are owned by company insiders. Comparatively, 0.8% of Artelo Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer SPRB or ARTL? In the previous week, Spruce Biosciences and Spruce Biosciences both had 2 articles in the media. Spruce Biosciences' average media sentiment score of 1.44 beat Artelo Biosciences' score of 0.38 indicating that Spruce Biosciences is being referred to more favorably in the media. Company Overall Sentiment Spruce Biosciences Positive Artelo Biosciences Neutral SummarySpruce Biosciences beats Artelo Biosciences on 10 of the 17 factors compared between the two stocks. Remove Ads Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARTL vs. The Competition Export to ExcelMetricArtelo BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.85M$6.79B$5.57B$7.84BDividend YieldN/A2.81%5.37%4.05%P/E Ratio-0.307.2223.5818.67Price / SalesN/A203.73370.3188.62Price / CashN/A65.6738.1734.64Price / Book0.216.026.654.10Net Income-$9.29M$142.11M$3.20B$246.93M7 Day Performance-10.72%-8.39%-5.81%-3.62%1 Month Performance-18.97%-11.79%-1.02%-6.69%1 Year Performance-43.13%-14.47%7.66%-1.88% Artelo Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARTLArtelo Biosciences2.6474 of 5 stars$0.87-0.9%$5.50+534.4%-40.9%$2.85MN/A-0.305News CoverageSPRBSpruce Biosciences3.1882 of 5 stars$0.33-2.0%$2.50+657.8%-63.1%$13.63M$7.10M-0.3520Upcoming EarningsShort Interest ↓Positive NewsMTVAMetaVia2.1555 of 5 stars$1.58+1.9%$12.00+659.5%N/A$13.61MN/A0.0010News CoverageGap UpHCWBHCW Biologics1.4228 of 5 stars$0.30-1.2%N/A-83.9%$13.36M$3.50M-0.3040Earnings ReportUpcoming EarningsIPAImmunoPrecise Antibodies2.2402 of 5 stars$0.43+1.6%$5.00+1,062.8%-75.2%$13.36M$24.07M-0.5580Earnings ReportAnalyst ForecastShort Interest ↑News CoverageGap DownCTXRCitius Pharmaceuticals3.4181 of 5 stars$1.55+2.0%$54.50+3,416.1%-93.4%$13.32MN/A0.0020News CoveragePositive NewsGap DownATHAAthira Pharma2.5155 of 5 stars$0.34+2.4%$13.83+3,968.6%-89.8%$13.27MN/A-0.1240Positive NewsBMRABiomerica0.961 of 5 stars$0.71+3.6%N/A-31.9%$13.02M$5.58M-2.0960Positive NewsNERVMinerva Neurosciences3.8388 of 5 stars$1.85+2.8%$5.00+170.3%-34.1%$12.94MN/A-4.209ORGSOrgenesisN/A$2.69-4.0%N/AN/A$12.91M$662,000.000.00150Gap UpFLGCFlora Growth3.1702 of 5 stars$0.66+5.9%$5.00+661.3%-73.8%$12.77M$64.15M0.00280Short Interest ↓ Remove Ads Related Companies and Tools Related Companies Spruce Biosciences Alternatives MetaVia Alternatives HCW Biologics Alternatives ImmunoPrecise Antibodies Alternatives Citius Pharmaceuticals Alternatives Athira Pharma Alternatives Biomerica Alternatives Minerva Neurosciences Alternatives Orgenesis Alternatives Flora Growth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ARTL) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Artelo Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARTL Stock Free ARTL Stock Alerts